Public unlisted company Ecobiotics subsidiary Qbiotics will put its lead compound EBC-46 into human phase 1 trials in Aus/Sep this year. It'll be the first drug from Australia's tropical rainforest to go into human trials. If it works as well as it has in the animal trials it has the potential to be huge.
Public unlisted company Ecobiotics subsidiary Qbiotics will put...
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)